$12.380
-0.035 (-0.28%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
HCM 相似图表分析预测
Alphio's HCM stock price prediction model matches the current HUTCHMED (China) Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.44 (+0.50%). The 1-week path is $12.44 (+0.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 HUTCHMED (China) Ltd 股票吗？
HUTCHMED (China) Ltd is a good buy right now, primarily driven by its recent conditional approval for Fanregratinib, which is expected to enhance revenue growth. The current price is $12.38, and the forward P/E ratio is 14.41, indicating a more favorable valuation compared to its historical performance. Additionally, the stock has shown a 20-day change of +11.23%, suggesting positive momentum. However, the main risk is its high P/E ratio of 1103.79, which indicates potential overvaluation if future earnings do not meet expectations.
HCM 股价于 Friday 收于 $12.38，此前下跌 -0.28%
HUTCHMED (China) Ltd (HCM) last closed at $12.38, losing -0.28%. These facts feed the 1-day and 1-week HCM price prediction above.
分析师一致预期
HUTCHMED (China) Ltd（HCM）：买入 4、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
HUTCHMED (China) Ltd（HCM）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 HCM 最接近的股票，按相似度排序。
HCM 季节性分析
Historically the probability of a positive August return for HCM is 53.97%. October offers the highest probability of a positive month at 82.61%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。